• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
VINC

VINC

Vincerx Pharma, Inc.

OTCHealthcareBiotechnologyUS

USD0.01

-0.00 (-1.17%)

Company Profile

CEO

Raquel E. Izumi

IPO Date

2020-05-27

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$0.01

Prev. Close

$0.01

Day Low

$0.01

Day High

$0.01

52W Low

$0.00

52W High

$1.43

Market Cap

$0.00B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

9

Avg Positive

40.1%

Avg Negative

1.4%

Avg Neutral

58.7%

News Feed

4 Stocks With CEO Buys in the Past Month

GuruFocus·7/8/2021·↑ positive

Vincerx Pharma Presents Clinical Data on VIP512, its PTEFb/CDK9 Inhibitor, in Patients with Double-Hit Lymphoma at ASCO 2021

GlobeNewsWire·6/4/2021·↑ positive

Vincerx Pharma Announces First Patient Dosed in Phase 1b Study of VIP152 in MYC-Driven Relapsed or Refractory Aggressive Lymphomas and Advanced Solid Tumors

GlobeNewsWire·6/3/2021·↑ positive

Vincerx Pharma Reports First Quarter 2021 Financial Results and Provides a Corporate Update

GlobeNewsWire·5/17/2021·↑ positive

Vincerx Pharma Announces FDA Clearance of IND for Phase 1b Study of VIP152 in Chronic Lymphocytic Leukemia and Richter Syndrome

GlobeNewsWire·4/20/2021·↑ positive

Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021

GlobeNewsWire·4/10/2021·↑ positive

Vincerx Pharma Announces Formation of Scientific Advisory Board to Advance its Clinical Pipeline

GlobeNewsWire·4/1/2021·↑ positive

Vincerx Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021

GlobeNewsWire·3/10/2021·↑ positive

Vincera Pharma Announces Name Change to Vincerx

GlobeNewsWire·1/7/2021·↑ positive